Findings indicated high ALKBH5 expression correlated with elevated scores for genes associated with tumor immunity such as lymphocyte-specific kinase (LCK), major histocompatibility complex I (MHC-I), major histocompatibility complex II (MHC-II), and signal transducer and activator of transcription 1 (STAT1) in glioma patients [47]. Here, ALKBH5 is linked to central nervous system cancer.